ReShape Lifesciences

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: 31

Market Cap: -

Website

Introduction: ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.

Clinical Trials

ReShape Vest™ for the Treatment of Obesity (Europe)

Phase 2

Conditions: Obesity
Weight Loss

First Posted Date: 2019-04-17

Last Posted Date: 2020-02-24

Lead Sponsor: ReShape Lifesciences

Target Recruit Count: 65

Registration Number: NCT03918564

Locations: 🇪🇸
Hospital universitario de Bellvitge, Barcelona, Spain

vBloc Now - Registry

Conditions: Obesity, Morbid

First Posted Date: 2018-02-15

Last Posted Date: 2018-07-26

Lead Sponsor: ReShape Lifesciences

Target Recruit Count: 125

Registration Number: NCT03434522

Locations: 🇺🇸
Sky Ridge, Lone Tree, Colorado, United States
🇺🇸
Christiana Institute of Advanced Surgery, Newark, Delaware, United States

The ReNEW Study: Maestro® New Enrollment Post-Approval Study Protocol

Not Applicable

Active, not recruiting

Conditions: Obesity, Morbid

Interventions: Device: vBloc Maestro Rechargeable System
Other: vBloc Achieve Weight Management Program
Other: Control Weight Management (CWM) program

First Posted Date: 2017-05-09

Last Posted Date: 2019-05-22

Lead Sponsor: ReShape Lifesciences

Target Recruit Count: 4

Registration Number: NCT03145636

Locations: 🇺🇸
HonorHealth, Scottsdale, Arizona, United States
🇺🇸
Winthrop University Hospital, Mineola, New York, United States

A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese Subjects

Conditions: Obesity

Interventions: Device: Reshape Integrated Dual Balloon

First Posted Date: 2016-10-07

Last Posted Date: 2019-03-29

Lead Sponsor: ReShape Lifesciences

Target Recruit Count: 186

Registration Number: NCT02927665

Locations: 🇺🇸
Digestive Health Specialists of the Southeast, Dothan, Alabama, United States
🇺🇸
Barrington Surgeons, Barrington, Illinois, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States

and more 11 locations

A Prospective, Randomized Multicenter Study to Evaluate the Safety and Efficacy of the ReShape Duo™ Intragastric Balloon System in Obese Subjects

Not Applicable

Completed

Conditions: Obesity

Interventions: Device: ReShape Duo balloon
Other: Diet counseling
Other: Exercise counseling

First Posted Date: 2012-08-28

Last Posted Date: 2015-12-07

Lead Sponsor: ReShape Lifesciences

Target Recruit Count: 326

Registration Number: NCT01673698

Locations: 🇺🇸
Washington University in St. Louis, St. Louis, Missouri, United States
🇺🇸
Hamilton Medical Center, Dalton, Georgia, United States
🇺🇸
Marquette General Surgical Weight Loss Center, Marquette, Michigan, United States

and more 5 locations

The Safety and Efficacy of vBloc Therapy Delivered by the Maestro Rechargeable System for the Treatment of Obesity

Not Applicable

Conditions: Obesity

Interventions: Device: vBloc (Active Device)
Device: Sham (Non-active Device)

First Posted Date: 2011-04-04

Last Posted Date: 2017-08-30

Lead Sponsor: ReShape Lifesciences

Target Recruit Count: 239

Registration Number: NCT01327976

Locations: 🇺🇸
Scripps Clinic Nutrition & Metabolic Research Center, La Jolla, California, United States
🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States

and more 7 locations

The Safety and Efficacy of the ReShape Intragastric Balloon in Obese Subjects

Not Applicable

Completed

Conditions: Obesity

Interventions: Device: ReShape Intragastric Balloon
Other: Control Arm

First Posted Date: 2010-02-03

Last Posted Date: 2016-05-13

Lead Sponsor: ReShape Lifesciences

Target Recruit Count: 30

Registration Number: NCT01061385

ReShape Intragastric Balloon for the Treatment of Obesity

Not Applicable

Completed

Conditions: Obesity

Interventions: Device: ReShape Duo Balloon

First Posted Date: 2009-12-02

Last Posted Date: 2015-09-29

Lead Sponsor: ReShape Lifesciences

Target Recruit Count: 26

Registration Number: NCT01024465

Locations: 🇮🇹
Casa di Cura Solatrix, Rovereto, Italy
🇮🇹
Regional Hospital, Vicenza, Italy

Vagal Blocking for Obesity Control

Not Applicable

Conditions: Obesity

Interventions: Device: Active, implantable, intra-abdominal vagal blocking medical device

First Posted Date: 2007-11-09

Last Posted Date: 2012-02-02

Lead Sponsor: ReShape Lifesciences

Target Recruit Count: 120

Registration Number: NCT00555958

Locations: 🇲🇽
Instituto Nacional de la Nutrición Salvador Zubiran (INNSZ), Mexico City, Mexico
🇦🇺
Flinders Medical Centre, Bedford Park, South Australia, Australia
🇳🇴
National Center for Advanced Laparoscopic Surgery, St. Olavs University Hospital, Trondheim, Norway

and more 2 locations

EMPOWER Clinical Trial: Vagal Blocking for Obesity Control

Not Applicable

Completed

Conditions: Obesity

Interventions: Device: Therapy ON
Device: Therapy OFF

First Posted Date: 2007-08-27

Last Posted Date: 2018-08-24

Lead Sponsor: ReShape Lifesciences

Target Recruit Count: 294

Registration Number: NCT00521079

Locations: 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
HonorHealth (formerly Scottsdale Bariatric Center), Scottsdale, Arizona, United States
🇺🇸
Scripps Clinic, La Jolla, California, United States

and more 12 locations

Home Terms & Conditions Privacy Policy